Cargando…
STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation
Pancreatic ductal adenocarcinoma (PDAC) has a high mortality rate and poor prognosis. KRAS, TP53, CDKN2A, and SMAD4 are driver genes of PDAC and 30–75% patients have mutations in at least two of these four genes. Herein, we analyzed the relationship between these genes and prognosis of 762 patients...
Autores principales: | Hu, Shanshan, Chen, Xiao, Xu, Xiangxiang, Zheng, Chenlei, Huang, Wenqian, Zhou, Yi, Akuetteh, Percy David Papa, Yang, Hongbao, Shi, Keqing, Chen, Bicheng, Zhang, Qiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550692/ https://www.ncbi.nlm.nih.gov/pubmed/33134183 http://dx.doi.org/10.3389/fonc.2020.594224 |
Ejemplares similares
-
Differentiating TP53 Mutation Status in Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI-Derived Radiomics
por: Gao, Jing, et al.
Publicado: (2021) -
SIRT7 Deacetylates STRAP to Regulate p53 Activity and Stability
por: Yu, Miao, et al.
Publicado: (2020) -
DPP4 Inhibitor Attenuates Severe Acute Pancreatitis-Associated Intestinal Inflammation via Nrf2 Signaling
por: Zhou, Xiang, et al.
Publicado: (2019) -
Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
por: Hori, Yasuki, et al.
Publicado: (2015) -
On Strapping the Chest in Phthisis
por: McCrea, John
Publicado: (1874)